Back to Search Start Over

Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway.

Authors :
Seternes, Ole-Morten
Mikalsen, Theresa
Johansen, Bjarne
Michaelsen, Espen
Armstrong, Chris G
Morrice, Nick A
Turgeon, Benjamin
Meloche, Sylvain
Moens, Ugo
Keyse, Stephen M
Source :
EMBO Journal; 12/8/2004, Vol. 23 Issue 24, p4780-4791, 12p
Publication Year :
2004

Abstract

Extracellular signal-regulated kinase 3 (ERK3) is an atypical mitogen-activated protein kinase (MAPK), which is regulated by protein stability. However, its function is unknown and no physiological substrates for ERK3 have yet been identified. Here we demonstrate a specific interaction between ERK3 and MAPK-activated protein kinase-5 (MK5). Binding results in nuclear exclusion of both ERK3 and MK5 and is accompanied by ERK3-dependent phosphorylation and activation of MK5 in vitro and in vivo. Endogenous MK5 activity is significantly reduced by siRNA-mediated knockdown of ERK3 and also in fibroblasts derived from ERK3<superscript>-/-</superscript> mice. Furthermore, increased levels of ERK3 protein detected during nerve growth factor-induced differentiation of PC12 cells are accompanied by an increase in MK5 activity. Conversely, MK5 depletion causes a dramatic reduction in endogenous ERK3 levels. Our data identify the first physiological protein substrate for ERK3 and suggest a functional link between these kinases in which MK5 is a downstream target of ERK3, while MK5 acts as a chaperone for ERK3. Our findings provide valuable tools to further dissect the regulation and biological roles of both ERK3 and MK5. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
02614189
Volume :
23
Issue :
24
Database :
Complementary Index
Journal :
EMBO Journal
Publication Type :
Academic Journal
Accession number :
15286858
Full Text :
https://doi.org/10.1038/sj.emboj.7600489